As of 2025-12-23, the Relative Valuation of Keros Therapeutics Inc (KROS) is 51.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 21.34 USD, the upside of Keros Therapeutics Inc based on Relative Valuation is 142.6%.
The range of the Relative Valuation is 37.86 - 76.99 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 25.5x | 21.7x |
| Forward P/E multiples | 18.1x - 36.4x | 27.2x |
| Fair Price | 37.86 - 76.99 | 51.77 |
| Upside | 77.4% - 260.8% | 142.6% |
| Date | P/E |
| 2025-12-19 | 9.58 |
| 2025-12-18 | 9.52 |
| 2025-12-17 | 9.85 |
| 2025-12-16 | 10.18 |
| 2025-12-15 | 10.04 |
| 2025-12-12 | 10.17 |
| 2025-12-11 | 10.25 |
| 2025-12-10 | 10.33 |
| 2025-12-09 | 10.18 |
| 2025-12-08 | 10.08 |
| 2025-12-05 | 10.25 |
| 2025-12-04 | 9.58 |
| 2025-12-03 | 8.56 |
| 2025-12-02 | 7.96 |
| 2025-12-01 | 8.12 |
| 2025-11-28 | 8.26 |
| 2025-11-26 | 8.27 |
| 2025-11-25 | 8.19 |
| 2025-11-24 | 8.04 |
| 2025-11-21 | 8.22 |
| 2025-11-20 | 7.95 |
| 2025-11-19 | 7.97 |
| 2025-11-18 | 8.30 |
| 2025-11-17 | 8.21 |
| 2025-11-14 | 8.16 |
| 2025-11-13 | 8.18 |
| 2025-11-12 | 8.26 |
| 2025-11-11 | 7.99 |
| 2025-11-10 | 8.06 |
| 2025-11-07 | 7.66 |
| 2025-11-06 | 7.64 |
| 2025-11-05 | 7.40 |
| 2025-11-04 | 7.35 |
| 2025-11-03 | 7.20 |
| 2025-10-31 | 7.20 |
| 2025-10-30 | 7.11 |
| 2025-10-29 | 7.11 |
| 2025-10-28 | 7.18 |
| 2025-10-27 | 7.11 |
| 2025-10-24 | 7.11 |
| 2025-10-23 | 7.03 |
| 2025-10-22 | 7.36 |
| 2025-10-21 | 7.29 |
| 2025-10-20 | 7.18 |
| 2025-10-17 | 6.54 |
| 2025-10-16 | 6.50 |
| 2025-10-15 | 6.85 |
| 2025-10-14 | 7.13 |
| 2025-10-13 | 7.51 |
| 2025-10-10 | 7.42 |